Prevention of vasospasm in subarachnoid hemorrhage
Completed
Phase N/A ResultsSummary of Purpose
To determine if the use of nimodipine reduces the severity of ischemic deficits secondary to vasospasm.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 26 April 2001.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
Prospective, randomized, double blind, placebo-controlled trial of 70 patients.
Contacts
Not available
Recruitment
- Gender: Both
- Minimum Age: 15
- Maximum Age: 65
- Study Size: 70
- Max Time from Onset: 72 Hours
- Follow Up: 21 Days
Principal Investigator
-
J Philippon
Service de Neurochirurgie, Hopital de la Salpetriere, Paris, France.
Locations
- Paris, France.